Alphanosos, a Green One-Health DeepTech company, discovers, with its genuine Artificial Intelligence-based methodology, develops and commercializes actives and products based on patent-pending mixes of edible plant extracts in the fields of animal hygiene and nutrition, dermo-cosmetics, and at longer-term, functional foods and disease treatments. Alphanosos’ current patent-pending and upcoming actives dislodge persistent bacterial communities present at the surface of organs and in cells, and which are often resistant to antibiotics and to the immune response such as to cause devastating chronic inflammatory diseases. Its technology has also been applied with success to the discovery of actives against cancer cell lines potentially amenable to cancer-preventive and curative treatments. Alphanosos R&D operation started in mid-2015 and it is now a commercial state company working essentially through commercial distributors and lcensing partnerships. Alphanosos’ actives currently target animal hygiene and nutrition and human dermo-cosmetics markets, including acne / psoriasis / eczema, dog pyoderma, and aquaculture, summing up to several billion Euros, to be complemented at longer-term by multi-billion functional foods and drugs in chronic inflammatory diseases and oncology markets.